Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick W Miller

Showing results (81-90 of 195) with videos related to

Pageof 20
Sort By:
Medicine|December 25, 2012
The clinical phenotypes of the juvenile idiopathic inflammatory myopathiesMona Shah, Gulnara Mamyrova, Ira N Targoff, et al.
Arthritis and Rheumatism|July 13, 2004
International consensus on preliminary definitions of improvement in adult and juvenile myositisLisa G Rider, Edward H Giannini, Hermine I Brunner, et al.
Arthritis Care & Research|August 9, 2013
Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophyGulnara Mamyrova, James D Katz, Robert V Jones, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 30, 2023
Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile MyositisMatthew A Sherman, Katherine Pak, Iago Pinal-Fernandez, et al.
Arthritis Care & Research|October 24, 2013
Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Gulnara Mamyrova, Peter A Lachenbruch, et al.
Plos One|October 11, 2017
Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004)Gregg E Dinse, Christine G Parks, Clarice R Weinberg, et al.
Journal of Autoimmunity|November 25, 2019
Transethnic associations among immune-mediated diseases and single-nucleotide polymorphisms of the aryl hydrocarbon response gene ARNT and the PTPN22 immune regulatory geneShepherd H Schurman, Terrance P O'Hanlon, John A McGrath, et al.
Arthritis and Rheumatism|June 25, 2011
Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophanJeffrey A Allen, Alicia Peterson, Robert Sufit, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 2, 2022
Increasing Prevalence of Antinuclear Antibodies in the United StatesGregg E Dinse, Christine G Parks, Clarice R Weinberg, et al.
Pediatric Rheumatology Online Journal|April 13, 2022
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypesJonathan C Scalabrini, Adam I Schiffenbauer, Payam Noroozi Farhadi, et al.
Pageof 20

Showing results (81-90 of 195) with videos related to

Sort By:
Pageof 20
Medicine|December 25, 2012
The clinical phenotypes of the juvenile idiopathic inflammatory myopathiesMona Shah, Gulnara Mamyrova, Ira N Targoff, et al.
Arthritis and Rheumatism|July 13, 2004
International consensus on preliminary definitions of improvement in adult and juvenile myositisLisa G Rider, Edward H Giannini, Hermine I Brunner, et al.
Arthritis Care & Research|August 9, 2013
Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophyGulnara Mamyrova, James D Katz, Robert V Jones, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 30, 2023
Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile MyositisMatthew A Sherman, Katherine Pak, Iago Pinal-Fernandez, et al.
Arthritis Care & Research|October 24, 2013
Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathiesAdam M Huber, Gulnara Mamyrova, Peter A Lachenbruch, et al.
Plos One|October 11, 2017
Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004)Gregg E Dinse, Christine G Parks, Clarice R Weinberg, et al.
Journal of Autoimmunity|November 25, 2019
Transethnic associations among immune-mediated diseases and single-nucleotide polymorphisms of the aryl hydrocarbon response gene ARNT and the PTPN22 immune regulatory geneShepherd H Schurman, Terrance P O'Hanlon, John A McGrath, et al.
Arthritis and Rheumatism|June 25, 2011
Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophanJeffrey A Allen, Alicia Peterson, Robert Sufit, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 2, 2022
Increasing Prevalence of Antinuclear Antibodies in the United StatesGregg E Dinse, Christine G Parks, Clarice R Weinberg, et al.
Pediatric Rheumatology Online Journal|April 13, 2022
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypesJonathan C Scalabrini, Adam I Schiffenbauer, Payam Noroozi Farhadi, et al.
Pageof 20